Use of baricitinib in treatment of COVID-19: a systematic review.

Ananyan Sampath Aditya Banerjee Shubham Atal Ratinder Jhaj

Published in: Medicinal research reviews (2023)

Baricitinib significantly improves clinical outcomes in hospitalized patients with COVID-19 pneumonia, and further evidence will establish the drug as a standard treatment among such patients.

Keyphrases

end stage renal disease
sars cov
coronavirus disease
ejection fraction
chronic kidney disease
newly diagnosed
emergency department
peritoneal dialysis
replacement therapy
mechanical ventilation
community acquired pneumonia